Urinary tract infection in primary care: state of the art
DOI:
https://doi.org/10.32385/rpmgf.v38i2.13337Keywords:
Urinary tract infection, Antibiotics, Antibiotic resistanceAbstract
Introduction: Urinary tract infection (UTI) is the second most prevalent infection in the community.
Aims: To determine the microorganisms responsible for UTI in Primary Health Care and their profile of sensitivity to antibiotics, as well as to evaluate if the approach of the UTI is concordant with the National Health Authority’s recommendations.
Methods: Observational and retrospective study in four primary health care centers in Almada. Patients aged 18 years or older, whose appointments were coded with ICPC-2’s problems (U71-Cystitis/Urinary Infection Other and U70-Pyelonephritis/Pyelitis) between July and December 2019 were included. The SClínico software and the MIMUF platform were chosen to collect data. The variables studied were: sex, age, type of UTI, urine culture request, empirical antibiotics, the result of urine culture, and antimicrobial sensitivity test.
Results: Of the 963 UTIs, 88.3% occurred in women, mainly between 68 and 77 years old (18.9%). The most prevalent type of UTI was uncomplicated cystitis in non-pregnant women (56.3%). Empirical antibiotic therapy was prescribed in 86.7% of the cases, with fosfomycin being the most used one (58.6%). Four hundred and five urine culture requests were made, most of them with a positive result. E. coli was the most frequently identified microorganism (66.4%), being the most prevalent in all age groups and in the different types of UTI. It was sensitive to fosfomycin in 63.7% of cases. In the global analysis of the different units, it was found that urine culture was in accordance with the national recommendation in 70.4% of the cases and that empirical antibiotics were in accordance in 63% of the UTI cases.
Conclusions: UTIs in the community are more frequent in women between 68 and 77 years old. The most prevalent bacterial microorganism is E.coli, with significant sensitivity to fosfomycin and nitrofurantoin.
Downloads
References
Tavares IV, Sá AB. Perfil de prescrição de antimicrobianos para as infecções do tracto urinário nos cuidados de saúde primários [Antimicrobial prescribing for urinary tract infection in primary health care]. Rev Port Med Geral Fam. 2014;30(2):85-100. Portuguese
Sun X, Gulliford MC. Reducing antibiotic prescribing in primary care in England from 2014 to 2017: population-based cohort study. BMJ Open. 2019;9(7):e023989.
Saha SK, Hawes L, Mazza D. Improving antibiotic prescribing by general practitioners: a protocol for a systematic review of interventions involving pharmacists. BMJ Open. 2018;8(4):e020583.
Infarmed. Recomendações sobre antibioterapia: orientações da Comissão Nacional de Farmácia e Terapêutica, nº 7, setembro 2018 [Internet]. Lisboa: Infarmed; 2018 [cited 2020 Nov 1]. Available from: https://www.infarmed.pt/documents/15786/1816213/Recomenda%C3%A7%C3%B5es+CNFT+sobre+Antibioterapia/ed0f1313-dd35-4745-8ca3-f90eb0ab9106
Correia C, Costa E, Peres A, Alves M, Pombo G, Estevinho L. Etiologia das infecções do tracto urinário e sua susceptibilidade aos antimicrobianos [Etiology of urinary tract infections and antimicrobial susceptibility of urinary pathogens]. Acta Med Port. 2007;20(6):543-9. Portuguese
European Centre for Disease Prevention and Control. Surveillance of antimicrobial resistance in Europe 2018 [homepage]. Stockholm: ECDC; 2019 [cited 2020 Nov 1]. Available from: https://www.ecdc.europa.eu/en/publications-data/surveillance-antimicrobial-resistance-europe-2018
Martins F, Vitorino J, Abreu A. Avaliação do perfil de susceptibilidade aos antimicrobianos de microrganismos isolados em urinas na Região do Vale do Sousa e Tâmega [Evaluation of the antimicrobial susceptibility profile of microorganisms isolated from urine in the region of Vale do Sousa and Tâmega]. Acta Med Port. 2010;23(4):641-6. Portuguese
Direção-Geral da Saúde. Terapêutica de infeções do aparelho urinário (comunidade): norma nº 015/2011, de 30/08/2011. Lisboa: DGS; 2011.
European Centre for Disease Prevention and Control. Summary of the latest data on antibiotic consumption in the European Union [homepage]. Stockholm: ECDC; 2017 Nov [cited 2020 Nov 01]. Available from: https://www.ecdc.europa.eu/en/publications-data/summary-latest-data-antibiotic-consumption-eu-2017
Downloads
Published
Issue
Section
License
Copyright (c) 2022 Portuguese Journal of Family Medicine and General Practice

This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
The authors will assign to the RPMGF the sole right to publish and distribute the content of the manuscript specified in this declaration via physical, electronic, broadcasting or any other medium that may come into existence. They also grant the RPMGF the right to use and exploit this manuscript, in particular by assigning, selling or licensing its content. This permission is permanent and takes effect from the moment the manuscript is submitted, has the maximum duration allowed by applicable Portuguese or international law and is of worldwide scope. The authors further declare that this assignment is made free of charge. If the RPMGF informs the authors that it is not going to publish their manuscript, the exclusive assignment of rights ceases forthwith.
The authors authorise the RPMGF (or any entity it may appoint) to act on their behalf when it believes that copyright may have been infringed.